Finally, the identification of GR in virtually non- or entirely non-hormone-dependent breast cancer cells, including triple negative breast carcinoma) (11), encourage further investigation into the action of GC in all types of breast cancer. This evidence concerns the gene NR3C1 and triple-negative breast carcinoma.